Please Wait.....

Report

G8 Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027

Industry Report I 2023-10-25 I 228 Pages I MarketLine

G8 Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027

Summary

The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The G8 countries contributed $774.7 billion in 2022 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 2.3% between 2018 and 2022. The G8 countries are expected to reach a value of $897.4 billion in 2027, with a CAGR of 3% over the 2022-27 period.
- Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $408.0 billion in 2022. This was followed by Japan and Germany, with a value of $92.3 and $83.2 billion, respectively.
- The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $463.0 billion in 2016, followed by Germany and Japan with expected values of $107.9 and $106.5 billion, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players' G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to Buy

- What was the size of the G8 pharmaceuticals market by value in 2022?
- What will be the size of the G8 pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the G8 pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the G8 pharmaceuticals market?

Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Group of Eight (G8) Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in France
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in Germany
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in Italy
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Pharmaceuticals in Japan
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Pharmaceuticals in Russia
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
14 Macroeconomic Indicators
14.1. Country data
15 Pharmaceuticals in The United Kingdom
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
16 Macroeconomic Indicators
16.1. Country data
17 Pharmaceuticals in The United States
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis
18 Macroeconomic Indicators
18.1. Country data
19 Company Profiles
19.1. Johnson & Johnson
19.2. Apotex, Inc.
19.3. Laboratoires Pierre Fabre SA
19.4. F. Hoffmann-La Roche Ltd
19.5. Boehringer Ingelheim GmbH
19.6. A Menarini Industrie Farmaceutiche Riunite Srl
19.7. Recordati S.p.A.
19.8. Chiesi Farmaceutici SpA
19.9. Daiichi Sankyo Co Ltd
19.10. Astellas Pharma Inc.
19.11. Takeda Pharmaceutical Company Limited
19.12. Mitsubishi Tanabe Pharma Corporation
19.13. Sanofi SA
19.14. Bayer AG
19.15. Les Laboratoires Servier
19.16. Novartis AG
19.17. GSK plc.
19.18. Merck & Co., Inc.
19.19. Pfizer Inc.
19.20. AstraZeneca PLC
20 Appendix
20.1. Methodology
20.2. About MarketLine

List of Tables
Table 1: G8 pharmaceuticals industry, revenue($bn), 2018-27
Table 2: G8 pharmaceuticals industry, revenue by country ($bn), 2018-22
Table 3: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2022-27
Table 4: Canada pharmaceuticals market value: $ billion, 2017-22
Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2022
Table 6: Canada pharmaceuticals market value forecast: $ billion, 2022-27
Table 7: Canada size of population (million), 2018-22
Table 8: Canada gdp (constant 2005 prices, $ billion), 2018-22
Table 9: Canada gdp (current prices, $ billion), 2018-22
Table 10: Canada inflation, 2018-22
Table 11: Canada consumer price index (absolute), 2018-22
Table 12: Canada exchange rate, 2018-22
Table 13: France pharmaceuticals market value: $ billion, 2017-22
Table 14: France pharmaceuticals market geography segmentation: $ billion, 2022
Table 15: France pharmaceuticals market value forecast: $ billion, 2022-27
Table 16: France size of population (million), 2018-22
Table 17: France gdp (constant 2005 prices, $ billion), 2018-22
Table 18: France gdp (current prices, $ billion), 2018-22
Table 19: France inflation, 2018-22
Table 20: France consumer price index (absolute), 2018-22
Table 21: France exchange rate, 2018-22
Table 22: Germany pharmaceuticals market value: $ billion, 2017-22
Table 23: Germany pharmaceuticals market geography segmentation: $ billion, 2022
Table 24: Germany pharmaceuticals market value forecast: $ billion, 2022-27
Table 25: Germany size of population (million), 2018-22
Table 26: Germany gdp (constant 2005 prices, $ billion), 2018-22
Table 27: Germany gdp (current prices, $ billion), 2018-22
Table 28: Germany inflation, 2018-22
Table 29: Germany consumer price index (absolute), 2018-22
Table 30: Germany exchange rate, 2018-22
Table 31: Italy pharmaceuticals market value: $ billion, 2017-22
Table 32: Italy pharmaceuticals market geography segmentation: $ billion, 2022
Table 33: Italy pharmaceuticals market value forecast: $ billion, 2022-27
Table 34: Italy size of population (million), 2018-22
Table 35: Italy gdp (constant 2005 prices, $ billion), 2018-22
Table 36: Italy gdp (current prices, $ billion), 2018-22
Table 37: Italy inflation, 2018-22
Table 38: Italy consumer price index (absolute), 2018-22
Table 39: Italy exchange rate, 2018-22
Table 40: Japan pharmaceuticals market value: $ billion, 2017-22
Table 41: Japan pharmaceuticals market geography segmentation: $ billion, 2022
Table 42: Japan pharmaceuticals market value forecast: $ billion, 2022-27
Table 43: Japan size of population (million), 2018-22
Table 44: Japan gdp (constant 2005 prices, $ billion), 2018-22
Table 45: Japan gdp (current prices, $ billion), 2018-22
Table 46: Japan inflation, 2018-22
Table 47: Japan consumer price index (absolute), 2018-22
Table 48: Japan exchange rate, 2018-22
Table 49: Russia pharmaceuticals market value: $ billion, 2017-22
Table 50: Russia pharmaceuticals market geography segmentation: $ billion, 2022
Table 51: Russia pharmaceuticals market value forecast: $ billion, 2022-27
Table 52: Russia size of population (million), 2018-22
Table 53: Russia gdp (constant 2005 prices, $ billion), 2018-22
Table 54: Russia gdp (current prices, $ billion), 2018-22
Table 55: Russia inflation, 2018-22
Table 56: Russia consumer price index (absolute), 2018-22
Table 57: Russia exchange rate, 2018-22
Table 58: United Kingdom pharmaceuticals market value: $ billion, 2017-22
Table 59: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2022
Table 60: United Kingdom pharmaceuticals market value forecast: $ billion, 2022-27
Table 61: United Kingdom size of population (million), 2018-22
Table 62: United Kingdom gdp (constant 2005 prices, $ billion), 2018-22
Table 63: United Kingdom gdp (current prices, $ billion), 2018-22
Table 64: United Kingdom inflation, 2018-22
Table 65: United Kingdom consumer price index (absolute), 2018-22
Table 66: United Kingdom exchange rate, 2018-22
Table 67: United States pharmaceuticals market value: $ billion, 2017-22
Table 68: United States pharmaceuticals market geography segmentation: $ billion, 2022
Table 69: United States pharmaceuticals market value forecast: $ billion, 2022-27
Table 70: United States size of population (million), 2018-22
Table 71: United States gdp (constant 2005 prices, $ billion), 2018-22
Table 72: United States gdp (current prices, $ billion), 2018-22
Table 73: United States inflation, 2018-22
Table 74: United States consumer price index (absolute), 2018-22
Table 75: United States exchange rate, 2018-22
Table 76: Johnson & Johnson: key facts
Table 77: Johnson & Johnson: Annual Financial Ratios
Table 78: Johnson & Johnson: Key Employees
Table 79: Johnson & Johnson: Key Employees Continued
Table 80: Apotex, Inc.: key facts
Table 81: Apotex, Inc.: Key Employees
Table 82: Laboratoires Pierre Fabre SA: key facts
Table 83: Laboratoires Pierre Fabre SA: Key Employees
Table 84: F. Hoffmann-La Roche Ltd: key facts
Table 85: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 86: F. Hoffmann-La Roche Ltd: Key Employees
Table 87: Boehringer Ingelheim GmbH: key facts
Table 88: Boehringer Ingelheim GmbH: Key Employees
Table 89: A Menarini Industrie Farmaceutiche Riunite Srl: key facts
Table 90: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees
Table 91: Recordati S.p.A.: key facts
Table 92: Recordati S.p.A.: Annual Financial Ratios
Table 93: Recordati S.p.A.: Key Employees
Table 94: Chiesi Farmaceutici SpA: key facts
Table 95: Chiesi Farmaceutici SpA: Key Employees
Table 96: Daiichi Sankyo Co Ltd: key facts
Table 97: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 98: Daiichi Sankyo Co Ltd: Key Employees
Table 99: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 100: Astellas Pharma Inc.: key facts
Table 101: Astellas Pharma Inc.: Annual Financial Ratios
Table 102: Astellas Pharma Inc.: Key Employees
Table 103: Takeda Pharmaceutical Company Limited: key facts
Table 104: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 105: Takeda Pharmaceutical Company Limited: Key Employees

List of Figures
Figure 1: G8 pharmaceuticals industry, revenue($bn), 2018-27
Figure 2: G8 Pharmaceuticals industry, revenue by country (%), 2022
Figure 3: G8 pharmaceuticals industry, revenue by country ($bn), 2018-22
Figure 4: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2022-27
Figure 5: Canada pharmaceuticals market value: $ billion, 2017-22
Figure 6: Canada pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 7: Canada pharmaceuticals market value forecast: $ billion, 2022-27
Figure 8: Forces driving competition in the pharmaceuticals market in Canada, 2022
Figure 9: Drivers of buyer power in the pharmaceuticals market in Canada, 2022
Figure 10: Drivers of supplier power in the pharmaceuticals market in Canada, 2022
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2022
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2022
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2022
Figure 14: France pharmaceuticals market value: $ billion, 2017-22
Figure 15: France pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 16: France pharmaceuticals market value forecast: $ billion, 2022-27
Figure 17: Forces driving competition in the pharmaceuticals market in France, 2022
Figure 18: Drivers of buyer power in the pharmaceuticals market in France, 2022
Figure 19: Drivers of supplier power in the pharmaceuticals market in France, 2022
Figure 20: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2022
Figure 21: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2022
Figure 22: Drivers of degree of rivalry in the pharmaceuticals market in France, 2022
Figure 23: Germany pharmaceuticals market value: $ billion, 2017-22
Figure 24: Germany pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 25: Germany pharmaceuticals market value forecast: $ billion, 2022-27
Figure 26: Forces driving competition in the pharmaceuticals market in Germany, 2022
Figure 27: Drivers of buyer power in the pharmaceuticals market in Germany, 2022
Figure 28: Drivers of supplier power in the pharmaceuticals market in Germany, 2022
Figure 29: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2022
Figure 30: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2022
Figure 31: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2022
Figure 32: Italy pharmaceuticals market value: $ billion, 2017-22
Figure 33: Italy pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 34: Italy pharmaceuticals market value forecast: $ billion, 2022-27
Figure 35: Forces driving competition in the pharmaceuticals market in Italy, 2022
Figure 36: Drivers of buyer power in the pharmaceuticals market in Italy, 2022
Figure 37: Drivers of supplier power in the pharmaceuticals market in Italy, 2022
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2022
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2022
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2022
Figure 41: Japan pharmaceuticals market value: $ billion, 2017-22
Figure 42: Japan pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 43: Japan pharmaceuticals market value forecast: $ billion, 2022-27
Figure 44: Forces driving competition in the pharmaceuticals market in Japan, 2022
Figure 45: Drivers of buyer power in the pharmaceuticals market in Japan, 2022
Figure 46: Drivers of supplier power in the pharmaceuticals market in Japan, 2022
Figure 47: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2022
Figure 48: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2022
Figure 49: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2022
Figure 50: Russia pharmaceuticals market value: $ billion, 2017-22
Figure 51: Russia pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 52: Russia pharmaceuticals market value forecast: $ billion, 2022-27
Figure 53: Forces driving competition in the pharmaceuticals market in Russia, 2022
Figure 54: Drivers of buyer power in the pharmaceuticals market in Russia, 2022
Figure 55: Drivers of supplier power in the pharmaceuticals market in Russia, 2022
Figure 56: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2022
Figure 57: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2022
Figure 58: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2022
Figure 59: United Kingdom pharmaceuticals market value: $ billion, 2017-22
Figure 60: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 61: United Kingdom pharmaceuticals market value forecast: $ billion, 2022-27
Figure 62: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2022
Figure 63: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2022
Figure 64: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2022
Figure 65: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2022
Figure 66: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2022
Figure 67: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2022
Figure 68: United States pharmaceuticals market value: $ billion, 2017-22
Figure 69: United States pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 70: United States pharmaceuticals market value forecast: $ billion, 2022-27
Figure 71: Forces driving competition in the pharmaceuticals market in the United States, 2022
Figure 72: Drivers of buyer power in the pharmaceuticals market in the United States, 2022
Figure 73: Drivers of supplier power in the pharmaceuticals market in the United States, 2022
Figure 74: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2022
Figure 75: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2022
Figure 76: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2022

Not Sure / Need Reassuring
- Confirm Content
  - Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
    
    Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
    
    Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
    
    Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
- Sample Pages
  - With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
    
    It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
    
    To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Check for Alternatives
  - Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
    
    To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
Prices / Formats / Delivery
- Prices
  - All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
    
    Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Discounts
  - As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
    
    Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
    
    To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Available Currencies
  - Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
    
    Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
    
    To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
- Licenses
  - License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Global Site License
  - The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
    
    It is important to note that this may exclude Parent Companies or Subsidiaries.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Formats
  - The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
    
    If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
- Delivery
  - Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
    
    Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
    
    If a delay in delivery is expected you will be informed about it immediately.
- Shipping Charges
  - As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
    
    If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
Ordering
- By Credit Card
  - We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
    
    Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
    
    For more information on PayU please visit: https://www.payu.pl/en/about-us
- By Money Transfer
  - If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
    
    With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
Security
- Website security
  - We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
    
    Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
- Credit Card Security
  - We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
    
    PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.